Supply of oncology medicinal products
Originaltitel der Bekanntmachung
Bulgaria – Pharmaceutical products – „Доставка на онкологични лекарствени продукти за нуждите на УМБАЛ" Света Екатерина“ ЕАД
Opportunity Score
Warum diese Bewertung?
Chance
62 / 100
Komplexität
68 / 100
Risikofaktoren
Electronic submission is required; failure to use the specified electronic channel could invalidate participation.
Missing wholesale/manufacturing/import authorization or, where applicable, narcotics licensing would likely make the bi...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- BGN 48M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of pharmaceutical products, specifically various oncology medicinal products.
- The procurement is a dynamic purchasing system (DPS), not a framework agreement.
Vollständige Zusammenfassung anzeigen
Dynamic purchasing system for supplying various oncology medicinal products to University Hospital "St. Ekaterina" EAD in Sofia. The notice indicates an estimated overall value of BGN 48,000,000 and electronic submission is required. The award criterion is lowest price. Participation is restricted by pharmaceutical wholesale/manufacturing/import licensing requirements, and the notice text suggests the actual call-off volumes depend on real needs within the available financial resource.
Risiken
Electronic submission is required; failure to use the specified electronic channel could invalidate participation.
Missing wholesale/manufacturing/import authorization or, where applicable, narcotics licensing would likely make the bi...
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Participants must hold a wholesale trade authorization for medicinal products issued by the Bulgarian Medicines Agency or an equivalent authorization from the relevant EU...
- Manufacturers may trade wholesale only for products covered by their manufacturing authorization; importers may trade wholesale only for products covered by their import...
Certifications
- If the offered products include narcotic substances, a valid license under the Bulgarian Narcotic Substances and Precursors Control Act is required where applicable.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
гр. София, BGR
Website
Auftraggeberprofil
Kennung
831605845
Tätigkeit
Health
Lose (1)
LOT-0001
Supply of oncology medicinal products
Supply of various oncology medicinal products for the needs of University Hospital "St. Ekaterina" EAD. Quantities in the technical specification are indicative only and do not bind the contracting authority to order the forecast volume. Actual execution will depend on real delivered products within the available financial resource. This lot is part of a DPS and the lot information is taken from the structured notice.
BGN 48M
Geschätzter Wert
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Обществената поръчка се възлага въз основа на икономически най- изгодна оферта, чрез критерия " най- ниска цена", съгласно чл.70, ал.2,т.1 от ЗОП.
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
„Доставка на онкологични лекарствени продукти за нуждите на УМБАЛ" Света Екатерина“ ЕАД
Originale TED-Beschreibung
ДСП се създава за доставка на различни видове онкологични лекарствени продукти за нуждите на УМБАЛ" Света Екатерина“ ЕАД. Посочените количества по Техническата спецификация са прогнозни и не пораждат задължения за Възложителя да ги възложи в прогнозния обем. Фактическото изпълнение на обществената поръчка ще се определи на базата на реално доставените лекарствени продукти, в рамките на финансовия ресурс.
Vergabedetails
- Veröffentlichungsdatum
- 05 Aug 2024
- Sprachen
- Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 473054-2024
Dokumente (1)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
62 / 100
Komplexität
68 / 100
Risikofaktoren
Electronic submission is required; failure to use the specified electronic channel could invalidate participation.
Missing wholesale/manufacturing/import authorization or, where applicable, narcotics licensing would likely make the bi...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications